⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VALN News
Valneva SE American Depositary Shares
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Valneva SE – VALN
globenewswire.com
VALN
PFE
Pfizer et Valneva annoncent que le candidat vaccin contre la maladie de Lyme démontre une forte efficacité dans l’essai de Phase 3 VALOR
globenewswire.com
PFE
VALN
Elaris Secures Exclusive Global License from Valneva for C. difficile Vaccine Program
prnewswire.com
VALN
Valneva Reports Full Year 2025 Audited Consolidated Financial Results
globenewswire.com
VALN
Valneva to Report Full Year 2025 Consolidated Financial Results on March 18, 2026
globenewswire.com
VALN
Valneva to Participate in Upcoming Investor Conferences
globenewswire.com
VALN
Valneva Reports Preliminary Unaudited 2025 Revenue and Cash and Provides 2026 Outlook
globenewswire.com
VALN
Valneva Provides Update on Recommendations for Use of IXCHIQ® in the United Kingdom
globenewswire.com
VALN
Valneva and Instituto Butantan Announce Initiation of a Pilot Vaccination Campaign in Brazil with Single-Shot Chikungunya Vaccine IXCHIQ®
globenewswire.com
VALN
Valneva Provides Update on Chikungunya Vaccine IXCHIQ®
globenewswire.com
VALN